Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMoving to 10mg tirzepatide is worth careful thought rather than a quick decision. The 10mg dose is the fourth step in Mounjaro's six-step schedule, and for many people it marks the transition from tolerability work into more meaningful therapeutic territory — but going up early, or without the right clinical picture, is where things can go wrong. This is a prescription-only medicine, and every dose change needs a prescriber's sign-off based on your individual response.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misunderstanding about Mounjaro titration is that the 10mg pen will produce noticeably faster weight loss than 7.5mg from week one. It may not. Tirzepatide works partly by reducing appetite and slowing gastric emptying, and your body takes several weeks to reach a new steady state after each dose change. The early weeks of any new dose are an adjustment period, not a performance window.
Rushing to 10mg to break through a plateau is tempting, and honestly, that frustration is understandable after weeks of slower progress. But a temporary stall during titration is different from a dose that has genuinely stopped working. The NHS tirzepatide information page is clear that dose increases follow a structured schedule, not a results target. Treating the number as the goal rather than the clinical response is how people end up with avoidable nausea, vomiting or diarrhoea that sets their progress back further.
The better question is not "how quickly can I reach 10mg?" but "has 7.5mg had a fair trial?" That means at least four weeks at the current dose, side effects that have settled to a manageable level, and if you're asking whether moving up to 5mg Mounjaro was the right call earlier in your journey, that same reasoning applies at every subsequent step.
Three things should align before a move to 10mg is clinically appropriate. First, you've spent at least four weeks at 7.5mg, that four-week minimum is built into the licensed titration schedule and exists for a reason. Second, the GI effects from 7.5mg have settled. Nausea, loose stools and indigestion are most pronounced in the first one to two weeks after a step-up; if they're still significant at week three or four, increasing the dose will almost certainly worsen them. Third, your prescriber has reviewed your response and is satisfied the increase is appropriate.
For guidance on what the 7.5mg step itself involves before you progress, the page on moving to 7.5mg Mounjaro covers the same logic one step back. There's also a broader look at when the right time to go up a dose actually is, which is useful if you're unsure whether your current dose has been given a fair run.
One thing worth knowing: at nume, at nume, every repeat order includes a clinical review. A prescriber looks at your progress notes before any dose increase is approved. That review isn't a formality; it's where questions like this get answered properly.
The side-effect profile of tirzepatide is primarily gastrointestinal. Nausea, vomiting, constipation, diarrhoea, indigestion and burping are all listed as common effects, and they tend to peak just after a dose increase before gradually settling. Moving from 7.5mg to 10mg typically produces a fresh wave of these effects, milder for some people than the original step-up, more significant for others.
The BNF entry for tirzepatide sets out the full side-effect and monitoring picture. For the detailed patient-level information, the Mounjaro SmPC on the eMC gives the complete list alongside storage and administration guidance, your prescriber or pharmacist can point you to it. If you experience severe, persistent stomach pain that radiates to the back, that needs urgent medical attention regardless of where you are in the titration schedule; the MHRA highlighted acute pancreatitis as a known though infrequent risk in its January 2026 Drug Safety Update for GLP-1 medicines.
Practical things that genuinely help during a step-up: smaller meals, eating slowly, avoiding high-fat foods in the first week or two, and staying hydrated. None of that is revolutionary, but patients who pay attention to it tend to tolerate increases better. If you're still uncertain about whether going up a dose on Mounjaro is the right move for you, that uncertainty is worth exploring with your prescriber before you commit to the change. If side effects at 10mg remain unmanageable after two to three weeks, staying at 7.5mg longer is a legitimate clinical decision, not a failure.
Mounjaro's six licensed strengths go up to 15mg, and not everyone reaches the top. The aim is the highest dose you can tolerate effectively, not the highest dose available. Some people find their weight loss is satisfactory and their side effects well-managed at 10mg; others progress through 12.5mg to 15mg. There's no clinical prize for reaching 15mg if 10mg is doing the job, and the page on whether you should up your dose of Mounjaro walks through the considerations that help you and your prescriber reach that decision together.
If you're weighing up what treatment might cost as you move through the schedule, the Mounjaro cost page explains how private pricing works across the dose range. And if you'd like a broader view of where Mounjaro sits among available weight-loss treatments, our treatment overview covers the options a prescriber might discuss with you.
Decisions about progressing to 10mg are exactly the kind of thing a prescriber should weigh in on before you make the change. If you're not currently under clinical review for your Mounjaro treatment, starting a free consultation is the straightforward next step, a real prescriber reviews your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.